ABT GoodMoat Verdict
Full signal breakdown coming soon. Use the X-Ray tool for a detailed analysis.
Abbott Laboratories
Exchange: NYSESector: HealthcareIndustry: Medical Devices
Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 122,000 colleagues serve people in more than 160 countries. Connect with us at www.abbott.com and on LinkedIn, Facebook, Instagram, X and YouTube. i Mehdi, A., Taliercio, J. J., & Nakhoul, G. (2020, November 1). Contrast media in patients with kidney disease: An update. Cleveland Clinic Journal of Medicine. https://www.ccjm.org/content/87/11/683#:~:text=Nevertheless%2C%20CI%2DAKI%20remains%20real,24%25%20of%20patients%2C%20respectively. ii Masoudi FA, Ponirakis A, de Lemos JA, Jollis JG, Kremers M, Messenger JC, et al. Trends in U.S. Cardiovascular Care: 2016 Report From 4 ACC National Cardiovascular Data Registries. J Am Coll Cardiol. 2017;69(11):1427–50. iii Cook S, Walker A, Hügli O, Togni M, Meier B. Percutaneous coronary interventions in Europe: prevalence, numerical estimates, and projections based on data up to 2004. Clin Res Cardiol. 2007;96(6):375-382. doi:10.1007/s00392-007-0513-0. SOURCE Abbott
Current Price
$88.38
-0.50%GoodMoat Value
$72.81
17.6% overvaluedProfile
Valuation (TTM)
Market Cap$153.58B
P/E24.47
EV$186.31B
P/B2.91
Shares Out1.74B
P/Sales3.40
Revenue$45.13B
EV/EBITDA15.24
Abbott Laboratories (ABT) Quality Analysis
ABT Profitability
Profitability trend analysis coming soon
ABT Growth
Growth trend analysis coming soon
ABT Financial Health
Financial health indicators coming soon
ABT Quality & Fundamental Analysis
Abbott Laboratories (ABT) is a Healthcare company in the Medical Devices industry, listed on NYSE. This quality analysis page evaluates Abbott Laboratories's financial health using the Piotroski F-Score methodology, profitability ratios, growth trajectory, and balance sheet strength.
Abbott Laboratories has a Piotroski F-Score of N/A out of 9, measuring profitability, leverage, and operating efficiency. The company operates with a profit margin of 13.91% and a return on equity (ROE) of 11.89%. Return on assets (ROA) stands at 7.24%.
The debt-to-equity ratio is 0.25, with a current ratio of 1.58. Operating margin is 18.17%.
GoodMoat's quality analysis uses AI-powered insights to evaluate whether Abbott Laboratories is a fundamentally sound investment. The GoodMoat Verdict synthesizes profitability, growth, and financial health scores into a clear investment quality rating. Use these metrics alongside valuation tools like the DCF calculator and fair value models to make informed investment decisions.